Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.63 |
| ▸ | RAB9A | P51151 | 3/20 | 0.63 |
| ▸ | NPC1 | O15118 | 2/20 | 0.63 |
| ▸ | GAA | P10253 | 2/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.62 |
| ▸ | MEN1 | O00255 | 3/20 | 0.62 |
| ▸ | CA12 | O43570 | 1/20 | 0.60 |
| ▸ | CA1 | P00915 | 1/20 | 0.60 |
| ▸ | CA2 | P00918 | 1/20 | 0.60 |
| ▸ | ESR1 | P03372 | 1/20 | 0.60 |
| ▸ | CA7 | P43166 | 1/20 | 0.60 |
| ▸ | CA9 | Q16790 | 1/20 | 0.60 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.60 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | MAOA | P21397 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethyl Benzoate SCHEMBL55674 | 0.94 | LMNA (0.70) | LMNASMN1; SMN2RAB9ANPC1GAA | |
| Ethyl Benzoate SCHEMBL2762273 | 0.94 | LMNA (0.70) | LMNASMN1; SMN2RAB9ANPC1GAA | |
| Ethyl Benzoate SCHEMBL25388294 | 0.94 | LMNA (0.70) | LMNASMN1; SMN2RAB9ANPC1GAA | |
| Ethyl Benzoate SCHEMBL28871046 | 0.92 | LMNA (0.68) | LMNASMN1; SMN2RAB9ANPC1GAA | |
| Ethyl Benzoate SCHEMBL28365249 | 0.92 | LMNA (0.68) | LMNASMN1; SMN2RAB9ANPC1GAA | |
| Ethyl Benzoate SCHEMBL29554608 | 0.92 | LMNA (0.68) | LMNASMN1; SMN2RAB9ANPC1GAA | |
| Ethyl Benzoate SCHEMBL30886688 | 0.92 | LMNA (0.68) | LMNASMN1; SMN2RAB9ANPC1GAA | |
| Ethyl Benzoate SCHEMBL595705 | 0.92 | LMNA (0.68) | LMNASMN1; SMN2RAB9ANPC1GAA | |
| Ethyl Benzoate SCHEMBL10340677 | 0.92 | LMNA (0.68) | LMNASMN1; SMN2RAB9ANPC1GAA | |
| Ethyl Benzoate SCHEMBL1404143 | 0.92 | LMNA (0.68) | LMNASMN1; SMN2RAB9ANPC1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024071313-A1 | COSMETIC COMPOSITION AND COSMETIC | 株式会社日本触媒 | 2024-04-04 | — | — | WO | disclosed |
| US-20240009092-A1 | COSMETIC COMPOSITION AND COSMETIC QUASI-DRUG INCLUDING LIPID PARTICLES CONTAINING PHOSPHOLIPID | NIPPON SHOKUBAI CO., LTD. (JP) | 2024-01-11 | — | — | US | disclosed |
| EP-3398585-B1 | EXTERNAL DERMAL COMPOSITION FOR ANTI-AGEING AND METHOD FOR PRODUCING THE SAME | HAYASHIBARA CO (JP) | 2020-02-26 | — | — | EP | disclosed |
| EP-1600143-B1 | SKIN PREPARATION FOR EXTERNAL USE CHARACTERIZED BY CONTAINING SUGAR DERIVATIVE OF a,a-TREHALOSE | HAYASHIBARA CO (JP) | 2019-07-10 | — | — | EP | disclosed |
| US-20190008747-A1 | EXTERNAL DERMAL COMPOSITION FOR ANTI-AGEING AND METHOD FOR PRODUCING THE SAME | Hayashibara Co., Ltd. (JP) | 2019-01-10 | — | — | US | disclosed |
| EP-3398585-A1 | EXTERNAL DERMAL COMPOSITION FOR ANTI-AGEING AND METHOD FOR PRODUCING THE SAME | Hayashibara Co., Ltd. (JP) | 2018-11-07 | — | — | EP | disclosed |
| US-10111822-B2 | External dermal composition for anti-ageing and method for producing the same | Hayashibara Co., Ltd. (JP) | 2018-10-30 | — | — | US | disclosed |
| EP-2939657-B1 | SKIN-EXTERIOR ANTI-AGEING COMPOSITION AND PRODUCTION METHOD THEREFOR | HAYASHIBARA CO (JP) | 2018-08-08 | — | — | EP | disclosed |
| EP-3143983-A1 | EXTERNAL DERMATOLOGICAL FORMULATION COMPRISING SACCHARIDE DERIVATIVE OF ALPHA, ALPHA-TREHALOSE | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2017-03-22 | — | — | EP | disclosed |
| US-20150342854-A1 | EXTERNAL DERMAL COMPOSITION FOR ANTI-AGEING AND METHOD FOR PRODUCING THE SAME | Hayashibara Co., Ltd. (JP) | 2015-12-03 | — | — | US | disclosed |
| EP-2939657-A1 | SKIN-EXTERIOR ANTI-AGEING COMPOSITION AND PRODUCTION METHOD THEREFOR | Hayashibara Co., Ltd. (JP) | 2015-11-04 | — | — | EP | disclosed |
| US-7854922-B2 | Skin preparation for external use characterized by containing sugar derivative of α, α-trehalose | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2010-12-21 | — | — | US | disclosed |
| US-20070003502-A1 | Skin preparation for external use characterized by containing sugar derivative of alpha, alpha-trehalose | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2007-01-04 | — | — | US | disclosed |
| EP-1600143-A1 | SKIN PREPARATION FOR EXTERNAL USE CHARACTERIZED BY CONTAINING SUGAR DERIVATIVE OF a,a-TREHALOSE | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo (JP) | 2005-11-30 | — | — | EP | disclosed |
| US-5695867-A | LAMINATE BODY COMPRISING A BINDER SANDWICHED BETWEEN A CONSTRAINING LAYER AND A VULCANIZED RUBBER; ADHESION, SHAPING | LINTEC CORPORATION (JP) | 1997-12-09 | — | — | US | disclosed |
| EP-0340262-A4 | SEMI-PERMEABLE MEMBRANES WITH AN INTERNAL DISCRIMINATING REGION | — | 1990-09-26 | — | — | EP | disclosed |
| WO-1989004206-A1 | SEMI-PERMEABLE MEMBRANES WITH AN INTERNAL DISCRIMINATING REGION | THE DOW CHEMICAL COMPANY (US) | 1989-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240009092-A1 | COSMETIC COMPOSITION AND COSMETIC QUASI-DRUG INCLUDING LIPID PARTICLES CONTAINING PHOSPHOLIPID | PLIN5, PHOSPHO1, PLIN3 | LMNA 2074/4885SMN1; SMN2 4419/4885RAB9A 991/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.